Georgia Tech Using CRISPR-Chip Technology, Cardea Bio Aims to Develop Lab-Free Multi-Omic Technology Premium The company showed that its chip can detect SNPs in models of sickle-cell disease and amyotrophic lateral sclerosis, without the need for DNA amplification. Inflammatory Bowel Disease Genetic Risk Architecture Appears Distinct in African Americans Using whole-genome sequence data for thousands of African American individuals, researchers teased out ancestry effects on polygenic risk of the conditions. IARPA Commits $48M to DNA Data Storage Illumina, Twist Bioscience, and DNA Script are among the private sector collaborators of the groups receiving funds to develop technology platforms. Genetic Disease Risk Estimates May Be off in Populations Not Covered by GWAS A Georgia Tech team found that the reliance of genome-wide association studies on European populations has skewed estimates of disease risk in other populations. Metagenomics Shows Potential for Foodborne Pathogen Outbreak Investigations Premium Researchers from the CDC and Georgia Tech tested the efficacy of using whole-genome shotgun sequencing to diagnose food-borne pathogens in outbreaks. Sep 15, 2016 Ancestral Sequence Reconstruction Approaches Are Highly Accurate, Experimental Study Finds Nov 17, 2015 Metabolic Signature Reported to Distinguish Early-Stage Ovarian Cancer Jul 2, 2015 Georgia Tech Team Develops Computational Tool to ID Biologically Significant Protein Hotspots Premium Jan 26, 2015 Georgia Tech Group, Others Develop Methods to Map Ribonucleotides in Genomic DNA Oct 3, 2014 Study Suggests Biased Gene Conversion Can Ratchet up Homozygosity, Recessive Disease Risk Jul 17, 2013 Stanford, Georgia Team Evaluates WGS in Healthy Individuals Premium Jun 25, 2013 Funding Update: NSF Microarray Grants 2013 Premium May 24, 2013 $4M Grant Awarded to Emory University, Georgia Tech to Create Exposome Center Jan 28, 2013 Researchers Describe the Troposphere Microbiome Feb 24, 2012 Georgia Tech Researchers Tout RNA-seq Pipeline as Faster, More User Friendly for Cancer Research Premium Oct 28, 2010 Georgia Tech Leads $16M Zinc Finger Studies Oct 14, 2010 Q&A: Georgia Tech's Niren Murthy on Oral Delivery of siRNAs Premium Aug 20, 2010 Georgia Tech Team Claims 100 Percent Accuracy for Metabolomic Ovarian Cancer Test in Initial Trial Premium Jun 4, 2010 Janelia Farm, Georgia Tech Systems Bio Center Join Ranks of World's Fastest Supercomputers Premium Jun 4, 2010 Funding Update: Jun 4, 2010 Premium Sep 10, 2009 Approach Combining Proteomics and Genomics Allows Researchers to Examine Diversity in Shewanella Premium Sep 1, 2009 Systems Biology Provides Clues to Bacteria with Bioremediation Potential Aug 4, 2009 Clark Atlanta Starting Cancer Genomics Center with GT Jul 8, 2009 GRA Raises $18.75M in First Closing of Investment Fund for Georgia University Spinouts Premium May 1, 2009 Short Reads: May 1, 2009 Premium Load More Breaking News GA4GH Announces 10 New 'Driver' Projects, Including First Pediatric Partner Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.